about
Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseasesSomatic mutations activating STAT3 in human inflammatory hepatocellular adenomasExpression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers.High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesionsFrequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursSTAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer.Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer.Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.AAV2 and Hepatocellular Carcinoma.Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV.Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision ImmunotherapyGenotype-phenotype correlation ofCTNNB1mutations reveals different ß-catenin activity associated with liver tumor progressionErratum: Corrigendum: High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesionsGNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
P50
Q28821025-B1EEF72B-F9FE-4989-86FF-12AA6A033CFDQ35102345-DF87925C-340D-49A8-A41B-A916DC69414EQ36287075-C40B8FE0-F0BE-4E83-97E4-690B694914CFQ37064910-D6095BAC-A892-4A2A-82B0-139DB81CAA4EQ37224637-D161BA98-A3EF-4F23-84C3-65FB2D1E177DQ37273194-EBFDC576-2A96-4388-82C0-A7617349E807Q37554449-D7CC9921-5CFD-46D4-A81D-4797D448142EQ38222512-9A275B0C-1063-4D29-82E2-CD902663F3A4Q38549928-F3D77E22-C120-4143-9637-51DC39848797Q39003817-E58A6787-F8A9-4C0B-8115-49A412D51CD2Q39113102-67AA7745-D8C6-4907-ACBF-B23343B84E61Q39370240-46F37FEC-EF05-4968-8B0E-52B94CD54FBBQ40613665-8D4C98ED-6921-4E76-A65C-50A29819EA16Q40876157-7C472A1E-D409-43FF-8739-693230CE5D6FQ42749767-5827EEFE-45AA-431F-9684-83342401DECDQ48305502-F96102E7-5425-4395-9FDE-177C2D6779DAQ48679364-AA44001A-1248-42B1-90C7-2A4AFA630C82Q56965582-87FBF9FB-3C8E-4EC1-9094-90334670635BQ59938913-2F02D9F8-AD14-4C70-9800-B5CAA3F3AB44Q61160344-0FD8C487-AAFD-46B2-8977-0B2D5D70EEA9Q64041199-4206B219-5D2A-4D17-B444-1FEEEE515353
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Camilla Pilati
@ast
Camilla Pilati
@en
Camilla Pilati
@es
Camilla Pilati
@nl
Camilla Pilati
@sl
type
label
Camilla Pilati
@ast
Camilla Pilati
@en
Camilla Pilati
@es
Camilla Pilati
@nl
Camilla Pilati
@sl
prefLabel
Camilla Pilati
@ast
Camilla Pilati
@en
Camilla Pilati
@es
Camilla Pilati
@nl
Camilla Pilati
@sl
P106
P21
P31
P496
0000-0002-1781-5180